122 related articles for article (PubMed ID: 10748039)
1. Recombinant fibrinogen Vlissingen/Frankfurt IV. The deletion of residues 319 and 320 from the gamma chain of firbinogen alters calcium binding, fibrin polymerization, cross-linking, and platelet aggregation.
Hogan KA; Gorkun OV; Lounes KC; Coates AI; Weisel JW; Hantgan RR; Lord ST
J Biol Chem; 2000 Jun; 275(23):17778-85. PubMed ID: 10748039
[TBL] [Abstract][Full Text] [Related]
2. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
Koopman J; Haverkate F; Briët E; Lord ST
J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
[TBL] [Abstract][Full Text] [Related]
3. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites.
Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N
Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960
[TBL] [Abstract][Full Text] [Related]
4. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
5. A functional assay suggests that heterodimers exist in two C-terminal gamma-chain dysfibrinogens: Matsumoto I and Vlissingen/Frankfurt IV.
Hogan KA; Lord ST; Okumura N; Terasawa F; Galanakis DK; Scharrer I; Gorkun OV
Thromb Haemost; 2000 Apr; 83(4):592-7. PubMed ID: 10780323
[TBL] [Abstract][Full Text] [Related]
6. The polymerization pocket "a" within the carboxyl-terminal region of the gamma chain of human fibrinogen is adjacent to but independent from the calcium-binding site.
Côté HC; Pratt KP; Davie EW; Chung DW
J Biol Chem; 1997 Sep; 272(38):23792-8. PubMed ID: 9295325
[TBL] [Abstract][Full Text] [Related]
7. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links.
Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113
[TBL] [Abstract][Full Text] [Related]
8. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a mouse model of the dysfibrinogen Vlissingen/Frankfurt IV.
Hogan KA; Maeda N; Kluckman KD; Lord ST
Ann N Y Acad Sci; 2001; 936():117-21. PubMed ID: 11460467
[TBL] [Abstract][Full Text] [Related]
10. Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation.
Lounes KC; Ping L; Gorkun OV; Lord ST
Biochemistry; 2002 Apr; 41(16):5291-9. PubMed ID: 11955079
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions.
Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST
Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918
[TBL] [Abstract][Full Text] [Related]
13. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
Mullin JL; Gorkun OV; Lord ST
Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
[TBL] [Abstract][Full Text] [Related]
14. Calcium-binding site beta 2, adjacent to the "b" polymerization site, modulates lateral aggregation of protofibrils during fibrin polymerization.
Kostelansky MS; Lounes KC; Ping LF; Dickerson SK; Gorkun OV; Lord ST
Biochemistry; 2004 Mar; 43(9):2475-83. PubMed ID: 14992585
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.
Hirota-Kawadobora M; Kani S; Terasawa F; Fujihara N; Yamauchi K; Tozuka M; Okumura N
J Thromb Haemost; 2005 May; 3(5):983-90. PubMed ID: 15869595
[TBL] [Abstract][Full Text] [Related]
16. Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.
Okumura N; Gorkun OV; Terasawa F; Lord ST
Blood; 2004 Jun; 103(11):4157-63. PubMed ID: 14764520
[TBL] [Abstract][Full Text] [Related]
17. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
Terasawa F; Kani S; Hongo M; Okumura N
Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
[TBL] [Abstract][Full Text] [Related]
18. The impaired polymerization of fibrinogen Longmont (Bbeta166Arg-->Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers.
Lounes KC; Lefkowitz JB; Henschen-Edman AH; Coates AI; Hantgan RR; Lord ST
Blood; 2001 Aug; 98(3):661-6. PubMed ID: 11468164
[TBL] [Abstract][Full Text] [Related]
19. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
20. The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His).
Siebenlist KR; Mosesson MW; Di Orio JP; Tavori S; Tatarsky I; Rimon A
Thromb Haemost; 1989 Nov; 62(3):875-9. PubMed ID: 2512677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]